Axel Kola
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 33
-
- Antibiotic Use and Resistance 12
- Endocrinology top 1%
-
- Nosocomial Infections in ICU 13
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 16
-
- Antimicrobial Resistance in Staphylococcus 16
- Clostridium difficile and Clostridium perfringens research 7
-
- Urinary Tract Infections Management 8
-
- Complement system in diseases 8
- Co-authors
- Petra GastmeierFrank SchwabJörg KöhlAndreas KlosWilfried BautschRasmus LeistnerYvonne PfeiferChristine Geffers
- Partner nations
- GermanyNetherlandsSpain
In The Last Decade
Axel Kola
66 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 111
- Molecular Medicine 929
- Applied Microbiology and Biotechnology 240
- Endocrinology 402
- Critical Care and Intensive Care Medicine 254
- Clinical Biochemistry 270
Countries citing papers authored by Axel Kola
This map shows the geographic impact of Axel Kola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Kola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Kola more than expected).
Fields of papers citing papers by Axel Kola
This network shows the impact of papers produced by Axel Kola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Kola. The network helps show where Axel Kola may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Axel Kola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 127 | |
| 9 | 2020 | 44 | |
| 10 | 2019 | 41 | |
| 11 | 2017 | 9 | |
| 12 | 2016 | 21 | |
| 13 | 2015 | 105 | |
| 14 | 2014 | 80 | |
| 15 | 2012 | 76 | |
| 16 | 2011 | 53 | |
| 17 | 2010 | 45 | |
| 18 | 2009 | 20 | |
| 19 | 2004 | 56 | |
| 20 | 1997 | 15 |
About Axel Kola
Axel Kola is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine, having authored 66 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (33 papers), Antimicrobial Resistance in Staphylococcus (16 papers), Bacterial Identification and Susceptibility Testing (16 papers), Nosocomial Infections in ICU (13 papers), Antibiotic Use and Resistance (12 papers), Urinary Tract Infections Management (8 papers), Complement system in diseases (8 papers) and Clostridium difficile and Clostridium perfringens research (7 papers). The work is most often cited by research in Molecular Medicine (929 citations), Applied Microbiology and Biotechnology (240 citations) and Endocrinology (402 citations). Axel Kola has collaborated with scholars based in Germany, Netherlands and Spain. Frequent co-authors include Petra Gastmeier, Frank Schwab, Jörg Köhl, Andreas Klos, Wilfried Bautsch, Rasmus Leistner, Yvonne Pfeifer, Christine Geffers, Michael Behnke and Brar Piening.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.